質量分析市場規模、シェア、動向、2031年までの世界予測

世界の質量分析市場は、2026年の70億7,400万米ドルから2031年には107億8,330万米ドルに達し、2026年から2031年にかけて8.8%の年平均成長率（CAGR）で推移すると予測されています。

世界の質量分析市場は、医薬品、バイオテクノロジー、臨床診断、食品安全、環境といった各分野において、精密医療、バイオ医薬品開発、マルチオミクス研究、および規制対応型の生物学的分析試験が急速に拡大していることを背景に、力強い成長を遂げています。市場の成長を加速させている最新のトレンドの一つとして、スループット、再現性、および業務効率の向上を目的とした、高分解能LC-MS/MSやハイブリッド質量分析プラットフォームの導入拡大が挙げられます。これらには、AIを活用した分析機能、自動化、クラウド連携型ラボワークフロー、ロボットによるサンプル前処理などが統合されています。製薬・バイオ医薬品企業は、バイオマーカーの探索、抗体薬物複合体（ADC）の特性解析、細胞・遺伝子治療の開発、FDA（米国食品医薬品局）準拠の薬物動態解析などを目的として、高度な質量分析システムへの投資を積極的に行っています。一方、病院や診断検査機関では、内分泌、毒性学、精密腫瘍学（プレシジョン・オンコロジー）分野の検査向けに、卓上型臨床用LC-MS/MSシステムの導入が進んでいます。さらに、CRO（医薬品開発受託機関）による生物学的分析サービスの急成長、PFAS（有機フッ素化合物）や環境汚染物質の検査需要の増加、そしてデジタル統合・標準化された分析エコシステムへの移行といった動きも、次世代のハイブリッド型およびハイスループット質量分析プラットフォームに対する世界的な需要をさらに高めています。

調査対象範囲

本調査レポートでは、製品、サンプル導入方式、用途、エンドユーザー、および地域別に質量分析市場を分析しています。市場拡大を牽引する要因や業界が直面している現状・展望を網羅し、市場の主要企業から中小企業までを含めた競争環境の詳細を提示します。また、5つの地域区分およびマイクロマーケット（細分化市場）分析に基づき、各市場セグメントの収益予測も行っています。

本レポートを購入するメリット

本レポートは、質量分析市場全体および各サブセグメントの収益予測に関する有益な情報を、市場の主要企業や新規参入企業に提供します。ステークホルダーは競争環境を把握することで、自社の事業をより効果的に位置づけ、適切な市場参入・展開戦略を策定できるようになります。さらに、主要な促進要因、阻害要因、課題、機会など、市場のダイナミクスに関する洞察も提供します。

本レポートでは、以下の項目に関する有益なデータを提供します。

• 市場浸透：質量分析市場における主要企業の製品ポートフォリオに関する詳細な分析
• 製品開発・イノベーション：質量分析市場における主要企業の製品ポートフォリオに関する詳細な分析
• 市場開拓：収益性の高い成長分野に関する有益なデータ
• 市場の多角化：質量分析市場における最近の動向や進展に関する詳細情報
• 競合分析：主要競合他社の製品、成長戦略、収益予測、および市場区分に関する包括的な評価

Report Description

The global mass spectrometry market is projected to reach USD 10,783.3 million by 2031 from USD 7,074.0 million in 2026, at a CAGR of 8.8% from 2026 to 2031.

The global mass spectrometry market is experiencing strong growth driven by the rapid expansion of precision medicine, biologics development, multi-omics research, and regulatory-driven bioanalytical testing across pharmaceutical, biotechnology, clinical diagnostics, food safety, and environmental sectors. One of the latest trends accelerating market growth is the increasing adoption of high-resolution LC-MS/MS and hybrid mass spectrometry platforms integrated with AI-enabled analytics, automation, cloud-connected laboratory workflows, and robotic sample preparation to improve throughput, reproducibility, and operational efficiency. Pharmaceutical and biopharmaceutical companies are heavily investing in advanced mass spectrometry systems for biomarker discovery, antibody-drug conjugate (ADC) characterization, cell and gene therapy development, and FDA-compliant pharmacokinetic analysis, while hospitals and diagnostic laboratories are increasingly deploying benchtop clinical LC-MS/MS systems for endocrinology, toxicology, and precision oncology testing. Additionally, the rapid growth of outsourced bioanalytical services through CROs, increasing PFAS and environmental contaminant testing, and the transition toward digitally integrated and standardized analytical ecosystems are further strengthening global demand for next-generation hybrid and high-throughput mass spectrometry platforms.

The instruments segment accounted for the largest share of the mass spectrometry market.

By product, the mass spectrometry market is segmented into instruments, software, and services. During the forecast period, the instruments segment is projected to hold the largest share of the mass spectrometry market owing to increasing investments in advanced analytical technologies across pharmaceutical, biotechnology, clinical research, and multi-omics applications. The growing demand for high-performance mass spectrometry instruments is being driven by the rising complexity of drug development workflows involving biologics, antibody-drug conjugates (ADCs), cell and gene therapies, and precision medicine initiatives. Pharmaceutical and biopharmaceutical companies are increasingly investing in next-generation mass spectrometry platforms with improved sensitivity, high-resolution analysis, automation, and AI-enabled workflow capabilities to enhance bioanalytical efficiency, accelerate research timelines, and ensure regulatory compliance. Furthermore, developed regions such as North America and Europe are witnessing faster instrument replacement and upgrade cycles due to continuous technological innovation and the increasing adoption of high-throughput analytical systems across research laboratories, hospitals, and clinical institutions.

“The LC-MS segment accounted for the largest share of the mass spectrometry market.”

By inlet type, the mass spectrometry market is segmented into GC-MS, LC-MS, ICP-MS, and other inlet types. During the forecast period, the LC-MS segment is expected to dominate the global mass spectrometry market owing to its widespread adoption across pharmaceutical, biotechnology, clinical diagnostics, food safety, and environmental testing applications. LC-MS is one of the most extensively utilized analytical techniques for the identification and quantification of complex biological and chemical compounds with high sensitivity and accuracy. The segment is witnessing significant growth due to increasing regulatory acceptance, expanding biologics and precision medicine research, and rising demand for advanced bioanalytical testing workflows. One of the major market trends driving LC-MS adoption is the implementation of ICH M10 bioanalytical method validation guidelines by the U.S. Food and Drug Administration and other international regulatory agencies, which recognize LC-MS/MS as the preferred technology for pharmacokinetic analysis, biomarker quantification, and regulated drug testing. This regulatory shift is encouraging pharmaceutical companies and contract research organizations to increase investments in next-generation LC-MS/MS platforms to support clinical development, regulatory compliance, and high-throughput drug analysis applications.

“The pharma/biopharma manufacturing application segment accounted for the largest share of the mass spectrometry market.”

The pharmaceutical and biopharmaceutical sectors are emerging as major application areas and key news trends in the mass spectrometry market due to the growing demand for advanced analytical technologies in drug discovery, biologics characterization, biomarker identification, and GMP-compliant quality control. Pharmaceutical companies are increasingly adopting LC-MS/MS and high-resolution mass spectrometry systems to support complex biologics, antibody-drug conjugates, peptides, cell and gene therapies, and biosimilar development, where traditional analytical methods are often insufficient. The rising focus on precision medicine, regulatory compliance, impurity profiling, and real-time process monitoring is further accelerating the adoption of advanced mass spectrometry platforms across pharmaceutical R&D and manufacturing operations.

In addition, the rapid expansion of omics research, proteomics, metabolomics, and personalized medicine is driving continuous innovation and product launches in the mass spectrometry industry. Leading companies are introducing automated, high-throughput, and AI-enabled mass spectrometry solutions to support translational research and biopharma workflows. The increasing outsourcing of bioanalytical testing to CROs and CDMOs, along with growing investments in biologics and advanced therapies, is further strengthening the role of mass spectrometry in pharmaceutical and biotechnology applications. These trends are positioning pharma and biopharma as the fastest-growing and highest-revenue-generating application segments within the global mass spectrometry market.

By end-user, the pharmaceutical companies segment is projected to account for the largest market share during the forecast period.

By end user, the mass spectrometry market is segmented into pharmaceutical companies, biotechnology companies, research laboratories & academic institutes, environmental testing laboratories, food & beverage industry, hospital clinical & forensic laboratories, petrochemical industry, and other end users. During the forecast period, the pharmaceutical companies segment is expected to register the fastest growth owing to the increasing adoption of advanced analytical technologies in biologics development, precision therapeutics, and multi-omics–based drug discovery workflows. One of the major trends driving growth in this segment is the rising deployment of advanced hybrid mass spectrometry platforms such as Orbitrap, Q-TOF, Triple Quadrupole Linear Ion Trap, and FT-MS systems for complex biologic characterization, antibody-drug conjugate (ADC) analysis, host-cell protein monitoring, and real-time process analytical technology (PAT) applications. Pharmaceutical and biopharmaceutical manufacturers are increasingly integrating high-resolution hybrid MS systems into manufacturing, quality control, and bioanalytical environments to support continuous bioprocessing, impurity profiling, glycosylation studies, and ultra-trace contaminant detection. This trend is particularly prominent in monoclonal antibody, mRNA, and cell therapy manufacturing facilities, where next-generation therapeutics require highly sensitive and high-resolution analytical capabilities beyond conventional testing technologies.

“Asia Pacific is projected to show the highest growth rate in the mass spectrometry market.”

The mass spectrometry market spans five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia-Pacific mass spectrometry market is witnessing rapid transformation driven by the expansion of biologics manufacturing, multi-omics research, precision medicine programs, and large-scale pharmaceutical outsourcing across China, India, Japan, South Korea, and Southeast Asia. One of the latest trends is the increasing deployment of high-resolution hybrid LC-MS/MS, Orbitrap, and Q-TOF systems in CROs, CDMOs, and biopharmaceutical manufacturing facilities for advanced biologic characterization, impurity profiling, glycan analysis, and cell & gene therapy workflows. Governments across the region are heavily investing in genomics, proteomics, metabolomics, and translational medicine initiatives, accelerating the adoption of AI-enabled and cloud-connected mass spectrometry platforms in both research and clinical diagnostics environments. Another major trend reshaping the region is the rapid digitalization of analytical laboratories through robotic sample preparation, laboratory information system (LIS) integration, and automated bioanalytical workflows to support high-throughput drug development and regulatory compliance. Additionally, APAC is emerging as a global pharmaceutical and bioanalytical outsourcing hub, creating strong recurring demand for advanced LC-MS infrastructure among CROs and contract testing laboratories.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Directors (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and Middle East & Africa (5%)

The major players in the mass spectrometry market include Thermo Fisher Scientific (US), Agilent Technologies (US), Sciex (US), Waters Corporation (US), Bruker (US), Shimadzu Corporation (Japan), and PerkinElmer Inc. (US), among others.

Research Coverage

The research report examines the mass spectrometry market by product, inlet type, application, end users, and region. This research covers factors that are driving market expansion, analyzes prospects and parameters faced by industries in the present time, and provides specifics on the competitive landscape, considering market leaders and small and medium enterprises. This research also estimates the revenue of different market segments by considering five regions and micro-market analysis.

Reasons to Buy the Report

The report will provide market leaders and new entrants with valuable information regarding the revenue estimates for the overall mass spectrometry market and its subsegments. It will help stakeholders understand the competitive landscape, allowing them to position their businesses more effectively and develop appropriate go-to-market strategies. Additionally, the report offers insights into the market dynamics, including key drivers, restraints, challenges, and opportunities.

This report provides insightful data on the following pointers:

• Market Penetration: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market
• Product Development/Innovation: In-depth coverage of product portfolios offered by the top players in the mass spectrometry market
• Market Development: Insightful data on profitable developing areas
• Market Diversification: Details about recent developments and advancements in the mass spectrometry market
• Competitive Assessment: Extensive assessment of the products, growth tactics, revenue projections, and market categories of the top competitors

Table of Contents

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.3 MARKET SCOPE 27
1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 27
1.3.2 INCLUSIONS AND EXCLUSIONS 28
1.3.3 YEARS CONSIDERED 29
1.4 CURRENCY CONSIDERED 29
1.5 STAKEHOLDERS 29
1.6 SUMMARY OF CHANGES 30
2 EXECUTIVE SUMMARY 31
2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 31
2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 32
2.3 DISRUPTIVE TRENDS IN MASS SPECTROMETRY MARKET 33
2.4 HIGH-GROWTH SEGMENTS 34
2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 35
3 PREMIUM INSIGHTS 36
3.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MASS SPECTROMETRY MARKET 36
3.2 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY INLET TYPE AND COUNTRY 37
3.3 MASS SPECTROMETRY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 38
4 MARKET OVERVIEW 39
4.1 INTRODUCTION 39
4.2 MARKET DYNAMICS 39
4.2.1 DRIVERS 40
4.2.1.1 Precision medicine & biomarker-driven healthcare system to drive adoption 40
4.2.1.2 Adoption of send‑out tests to control turnaround and cost 40
4.2.1.3 Increased privatization of environmental services and regulatory framework 40
4.2.1.4 Increasing investments in pharmaceutical research & development 41
4.2.2 RESTRAINTS 41
4.2.2.1 Capital-intensive investments for high-end equipment 41
4.2.2.2 Time-consuming sample preparation steps 42
4.2.3 OPPORTUNITIES 42
4.2.3.1 Growing application of mass spectrometry in clinical and forensic settings 42
4.2.3.2 Expansion of microbiome and infection diagnostics 42
4.2.3.3 Development of novel mass sensors and nanopore ion sources 42
4.2.4 CHALLENGES 43
4.2.4.1 Software interoperability and data management fragmentation 43
4.2.4.2 Inadequate infrastructure and shortage of skilled professionals 43
4.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 43
4.4 UNMET NEEDS 44
4.5 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 44
4.6 STRATEGIC MOVES BY TIER-1/2/3 PLAYERS 44
5 INDUSTRY TRENDS 46
5.1 PORTER’S FIVE FORCES ANALYSIS 46
5.1.1 BARGAINING POWER OF SUPPLIERS 47
5.1.2 BARGAINING POWER OF BUYERS 47
5.1.3 THREAT OF NEW ENTRANTS 47
5.1.4 THREAT OF SUBSTITUTES 47
5.1.5 INTENSITY OF COMPETITIVE RIVALRY 47
5.2 MACROECONOMIC OUTLOOK 48
5.2.1 INTRODUCTION 48
5.2.2 GDP TRENDS AND FORECAST 48
5.2.3 TRENDS IN MASS SPECTROMETRY INDUSTRY 48
5.3 VALUE CHAIN ANALYSIS 48
5.3.1 R&D 49
5.3.2 RAW MATERIAL PROCUREMENT 49
5.3.3 MANUFACTURING 50
5.3.4 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES 50
5.4 ECOSYSTEM ANALYSIS 50
5.5 PRICING ANALYSIS 51
5.5.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 52
5.5.2 AVERAGE SELLING PRICE TREND, BY REGION 53
5.6 TRADE ANALYSIS 56
5.6.1 IMPORT SCENARIO (HS CODE 902781) 56
5.6.2 EXPORT SCENARIO (HS CODE 902781) 57
5.7 KEY CONFERENCES AND EVENTS, 2026–2027 58
5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 58
5.9 INVESTMENT AND FUNDING SCENARIO 59
5.10 CASE STUDY ANALYSIS 61
5.11 IMPACT OF 2025 US TARIFF – MASS SPECTROMETRY MARKET 61
5.11.1 INTRODUCTION 61
5.11.2 KEY TARIFF RATES 62
5.11.3 PRICE IMPACT ANALYSIS 62
5.11.4 IMPACT ON COUNTRIES/REGIONS 63
5.11.4.1 US 63
5.11.4.2 Europe 63
5.11.4.3 Asia Pacific 63
5.11.5 IMPACT ON END-USE INDUSTRIES 63
6 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, AND INNOVATIONS 64
6.1 TECHNOLOGICAL ANALYSIS 64
6.1.1 KEY TECHNOLOGIES 64
6.1.1.1 Miniaturized ion trap and quadrupole mass analyzer 64
6.1.1.2 Quadrupole mass analyzer 64
6.1.1.3 Time-of-flight mass analyzer 64
6.1.1.4 Ion trap mass analyzer 65
6.1.2 COMPLEMENTARY TECHNOLOGIES 65
6.1.2.1 LC-MS 65
6.1.2.2 IOT sensor integration and environmental monitoring networks 65
6.1.3 ADJACENT TECHNOLOGIES 65
6.1.3.1 Mass spectrometry imaging 65
6.1.3.2 Ion mobility spectrometry 65
6.2 PATENT ANALYSIS 66
6.3 IMPACT OF AI ON MASS SPECTROMETRY MARKET 67
6.3.1 TOP USE CASES AND MARKET POTENTIAL 67
6.3.2 KEY COMPANIES IMPLEMENTING AI 68
6.3.3 BEST PRACTICES IN MASS SPECTROMETRY MARKET 68
6.3.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS 69
6.3.5 CLIENTS’ READINESS TO ADOPT AI IN MASS SPECTROMETRY 69
6.4 SUCCESS STORIES AND REAL-WORLD APPLICATIONS 69
7 REGULATORY LANDSCAPE 70
7.1 REGIONAL REGULATIONS AND COMPLIANCE 70
7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
7.1.2 REGULATORY SCENARIO 73
7.1.2.1 North America 73
7.1.2.2 Europe 73
7.1.2.3 Asia Pacific 73
7.1.2.4 Rest of the World 73
8 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR 74
8.1 DECISION-MAKING PROCESS 74
8.2 KEY STAKEHOLDERS AND BUYING CRITERIA 74
8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 74
8.2.2 KEY BUYING CRITERIA 75
8.3 UNMET NEEDS OF END USERS 76
8.4 MARKET PROFITABILITY 76
9 MASS SPECTROMETRY MARKET, BY OFFERING 77
9.1 INTRODUCTION 78
9.2 INSTRUMENTS 78
9.2.1 HYBRID MASS SPECTROMETRY INSTRUMENTS 79
9.2.1.1 Triple quadrupole MS 80
9.2.1.1.1 Enhanced selectivity, better accuracy, and greater reproducibility to drive adoption 80
9.2.1.2 Quadrupole-time of flight (Q-TOF) MS 81
9.2.1.2.1 Latest advances in Q-TOF mass spectrometry technology to streamline workflow, making it more efficient 81
9.2.1.3 Fourier transform MS 82
9.2.1.3.1 High-resolution biomolecule analysis to drive adoption 82
9.2.2 SINGLE MASS SPECTROMETRY INSTRUMENTS 83
9.2.2.1 Quadrupole MS 84
9.2.2.1.1 Wide application base in industry and academia to boost market growth 84
9.2.2.2 Time-of-flight MS 85
9.2.2.2.1 More precise results in proteomics and conventional analytical studies to favor adoption 85
9.2.2.3 Ion trap MS 86
9.2.2.3.1 More accurate results on higher mass-to-charge ratio extensions to favor adoption in specialized studies 86
9.2.3 OTHER MASS SPECTROMETRY INSTRUMENTS 87
9.3 SOFTWARE & SERVICES 88
9.3.1 NEED FOR EFFICIENT DATA MANAGEMENT AND PROCESSING TO PROPEL MARKET 88
10 MASS SPECTROMETRY MARKET, BY INLET TYPE 90
10.1 INTRODUCTION 91
10.2 LC-MS 92
10.2.1 REGULATORY SHIFTS WILL DRIVE ADOPTION OF LC-MS IN ENVIRONMENTAL TESTING 92
10.3 GC-MS 93
10.3.1 STANDARDIZED METHODS AND REGULATORY REFORMS FOR VOLATILE ORGANIC MOLECULES TO INCREASE ADOPTION OF GC-MS 93
10.4 ICP-MS 94
10.4.1 SIMPLE SAMPLE PREPARATION AND HIGH THROUGHPUT TO DRIVE GROWTH 94
10.5 OTHER INLET TYPES 95
11 MASS SPECTROMETRY MARKET, BY APPLICATION 97
11.1 INTRODUCTION 98
11.2 OMICS RESEARCH 98
11.2.1 RECENT ADVANCEMENTS IN BIOLOGICAL RESEARCH, PARTICULARLY IN PROTEOMICS AND GENOMICS, TO DRIVE MARKET 98
11.3 DRUG DISCOVERY 99
11.3.1 NEED FOR HIGHER EFFICACY AND PRODUCT QUALITY TO SUPPORT GROWTH 99
11.4 ENVIRONMENTAL TESTING 101
11.4.1 INCREASING NEED FOR MONITORING WATER CONTAMINATION TO PROPEL MARKET 101
11.5 FOOD TESTING 102
11.5.1 INCREASING IMPORTANCE OF SAFETY STANDARDS TO AMPLIFY GROWTH 102
11.6 PHARMA/BIOPHARMA MANUFACTURING 103
11.6.1 RISING USE OF MASS SPECTROMETRY IN PESTICIDE RESIDUE ANALYSIS, PROTEIN IDENTIFICATION, AND CARBON DATING TO AID GROWTH 103
11.7 CLINICAL DIAGNOSTICS 104
11.7.1 GROWING USE OF MASS SPECTROMETRY IN DRUG MONITORING, TOXICOLOGY, AND ENDOCRINOLOGY TO DRIVE MARKET 104
11.8 APPLIED SCIENCES 105
11.8.1 NEED FOR QUALITY CONTROL IN SEMICONDUCTOR INDUSTRY TO SUPPORT GROWTH 105
11.9 OTHER APPLICATIONS 106
12 MASS SPECTROMETRY MARKET, BY END USER 107
12.1 INTRODUCTION 108
12.2 PHARMACEUTICAL COMPANIES 108
12.2.1 GROWTH IN PHARMACEUTICAL SECTOR WILL FUEL DEMAND FOR MASS SPECTROMETRY 108
12.3 BIOTECHNOLOGY COMPANIES 109
12.3.1 GROWING BIOPHARMACEUTICAL APPLICATIONS TO DRIVE MARKET 109
12.4 RESEARCH LABS & ACADEMIC INSTITUTES 110
12.4.1 BREAKTHROUGH DEVELOPMENTS AND INDUSTRY-ACADEMIA PARTNERSHIPS TO PROPEL MARKET 110
12.5 ENVIRONMENTAL TESTING LABS 111
12.5.1 NEW AMENDMENTS IN ENVIRONMENTAL LAWS AND PRIVATIZATION OF TESTING SERVICES TO DRIVE MARKET 111
12.6 FOOD & BEVERAGE INDUSTRY 112
12.6.1 GROWING FOOD SAFETY CONCERNS TO SUPPORT MARKET GROWTH 112
12.7 FORENSIC LABS 113
12.7.1 ADVANCEMENTS IN TECHNOLOGY AND STRICT LAWS TO CREATE OPPORTUNITIES FOR MASS SPECTROMETRY 113
12.8 PETROCHEMICAL INDUSTRY 114
12.8.1 GROWING NUMBER OF NEW OIL & GAS FIELDS TO PROPEL MARKET 114
12.9 OTHER END USERS 115
13 MASS SPECTROMETRY MARKET, BY REGION 117
13.1 INTRODUCTION 118
13.2 NORTH AMERICA 119
13.2.1 US 123
13.2.1.1 Increased government investments and research funding to drive market 123
13.2.2 CANADA 125
13.2.2.1 Growing focus on clean energy technology to propel market 125
13.3 EUROPE 126
13.3.1 GERMANY 130
13.3.1.1 Growing pharmaceutical industry to drive market 130
13.3.2 UK 132
13.3.2.1 Industry academia partnerships to drive market 132
13.3.3 FRANCE 134
13.3.3.1 Strong environmental policies and public-funded research programs to drive demand 134
13.3.4 ITALY 135
13.3.4.1 Growing utilization of mass spectrometry among pharmaceutical and biotechnology end-use industries to drive market 135
13.3.5 SPAIN 137
13.3.5.1 Strong environmental monitoring framework to drive market 137
13.3.6 REST OF EUROPE 139
13.4 ASIA PACIFIC 140
13.4.1 JAPAN 145
13.4.1.1 Strong research infrastructure to drive demand for advanced MS models 145
13.4.2 CHINA 147
13.4.2.1 Increasing investments in scientific R&D to advance growth 147
13.4.3 INDIA 149
13.4.3.1 Increased government investments to drive market 149
13.4.4 SOUTH KOREA 151
13.4.4.1 Large industrial application base to drive demand for mass spectrometry 151
13.4.5 AUSTRALIA 153
13.4.5.1 Increasing focus on early cancer diagnosis and development of RNA therapies to aid growth 153
13.4.6 REST OF ASIA PACIFIC 155
13.5 LATIN AMERICA 156
13.5.1 BRAZIL 160
13.5.1.1 Increased local agricultural manufacturing to drive market growth 160
13.5.2 MEXICO 161
13.5.2.1 Growth in local manufacturing for pharmaceuticals to drive market 161
13.5.3 REST OF LATIN AMERICA 163
13.6 MIDDLE EAST & AFRICA 165
13.6.1 GCC COUNTRIES 168
13.6.1.1 Favorable government initiatives to support market growth 168
13.6.2 REST OF MIDDLE EAST & AFRICA 170
14 COMPETITIVE LANDSCAPE 172
14.1 OVERVIEW 172
14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 172
14.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN MASS SPECTROMETRY MARKET, JANUARY 2022–JUNE 2026 173
14.3 REVENUE ANALYSIS, 2021–2025 174
14.4 MARKET SHARE ANALYSIS, 2025 174
14.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 176
14.5.1 STARS 176
14.5.2 EMERGING LEADERS 177
14.5.3 PERVASIVE PLAYERS 177
14.5.4 PARTICIPANTS 177
14.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 178
14.5.5.1 Company footprint 178
14.5.5.2 Offering footprint 179
14.5.5.3 Application footprint 180
14.5.5.4 End-user footprint 181
14.5.5.5 Region footprint 182
14.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 183
14.6.1 PROGRESSIVE COMPANIES 183
14.6.2 RESPONSIVE COMPANIES 183
14.6.3 DYNAMIC COMPANIES 183
14.6.4 STARTING BLOCKS 183
14.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 185
14.6.5.1 Detailed list of key startups/SMEs, 2025 185
14.6.5.2 Competitive benchmarking of key startups/SMEs 186
14.7 COMPANY VALUATION & FINANCIAL METRICS 187
14.7.1 FINANCIAL METRICS 187
14.7.2 COMPANY VALUATION 188
14.8 BRAND COMPARISON 189
14.9 COMPETITIVE SCENARIO 190
14.9.1 PRODUCT LAUNCHES 190
14.9.2 DEALS 192
14.9.3 EXPANSIONS 193
15 COMPANY PROFILES 195
15.1 KEY PLAYERS 195
15.1.1 AGILENT TECHNOLOGIES, INC. 195
15.1.1.1 Business overview 195
15.1.1.2 Products offered 196
15.1.1.3 Recent developments 199
15.1.1.3.1 Product launches & approvals 199
15.1.1.3.2 Deals 200
15.1.1.3.3 Expansions 201
15.1.1.4 MnM view 201
15.1.1.4.1 Right to win 201
15.1.1.4.2 Strategic choices 202
15.1.1.4.3 Weaknesses & competitive threats 202
15.1.2 THERMO FISHER SCIENTIFIC INC. 203
15.1.2.1 Business overview 203
15.1.2.2 Products offered 204
15.1.2.3 Recent developments 206
15.1.2.3.1 Product launches 206
15.1.2.3.2 Deals 207
15.1.2.3.3 Expansions 209
15.1.2.4 MnM view 209
15.1.2.4.1 Right to win 209
15.1.2.4.2 Strategic choices 209
15.1.2.4.3 Weaknesses & competitive threats 210
15.1.3 WATERS CORPORATION 211
15.1.3.1 Business overview 211
15.1.3.2 Products Offered 212
15.1.3.3 Recent developments 214
15.1.3.3.1 Product launches 214
15.1.3.3.2 Deals 215
15.1.3.3.3 Expansions 216
15.1.3.4 MnM view 216
15.1.3.4.1 Right to win 216
15.1.3.4.2 Strategic choices 216
15.1.3.4.3 Weaknesses & competitive threats 216
15.1.4 DANAHER CORPORATION 217
15.1.4.1 Business overview 217
15.1.4.2 Products offered 218
15.1.4.3 Recent developments 220
15.1.4.3.1 Product launches 220
15.1.4.3.2 Deals 221
15.1.4.3.3 Expansions 221
15.1.4.4 MnM view 222
15.1.4.4.1 Right to win 222
15.1.4.4.2 Strategic choices 222
15.1.4.4.3 Weaknesses & competitive threats 222
15.1.5 BRUKER CORPORATION 223
15.1.5.1 Business overview 223
15.1.5.2 Products offered 224
15.1.5.3 Recent developments 226
15.1.5.3.1 Product launches & approvals 226
15.1.5.3.2 Deals 227
15.1.5.3.3 Expansions 228
15.1.5.3.4 Other developments 228
15.1.5.4 MnM view 229
15.1.5.4.1 Right to win 229
15.1.5.4.2 Strategic choices 229
15.1.5.4.3 Weaknesses & competitive threats 229
15.1.6 SHIMADZU CORPORATION 230
15.1.6.1 Business overview 230
15.1.6.2 Products offered 231
15.1.6.3 Recent developments 233
15.1.6.3.1 Product launches 233
15.1.6.3.2 Deals 234
15.1.6.3.3 Expansions 235
15.1.7 MKS INC. 236
15.1.7.1 Business overview 236
15.1.7.2 Products offered 237
15.1.8 PERKINELMER, INC. 238
15.1.8.1 Business overview 238
15.1.8.2 Products offered 239
15.1.8.3 Recent developments 240
15.1.8.3.1 Product launches 240
15.1.8.3.2 Deals 241
15.1.9 JEOL LTD 242
15.1.9.1 Business overview 242
15.1.9.2 Products offered 243
15.1.10 HITACHI HIGH-TECH CORPORATION 244
15.1.10.1 Business overview 244
15.1.10.2 Products offered 245
15.1.10.3 Recent developments 246
15.1.10.3.1 Other developments 246
15.1.11 TELEDYNE TECHNOLOGIES INCORPORATED 247
15.1.11.1 Business overview 247
15.1.11.2 Products offered 248
15.1.11.3 Recent developments 249
15.1.11.3.1 Product launches 249
15.1.11.3.2 Deals 249
15.1.12 AMETEK, INC. 250
15.1.12.1 Business overview 250
15.1.12.2 Products offered 251
15.1.12.3 Recent developments 252
15.1.12.3.1 Deals 252
15.1.13 JASCO 253
15.1.13.1 Business overview 253
15.1.13.2 Products offered 253
15.1.14 F. HOFFMANN-LA ROCHE LTD. 254
15.1.14.1 Business overview 254
15.1.14.2 Products offered 255
15.1.14.3 Recent developments 256
15.1.14.3.1 Product launches 256
15.1.14.3.2 Expansions 256
15.2 OTHER PLAYERS 257
15.2.1 ANALYTIK JENA GMBH 257
15.2.2 HIDEN ANALYTICAL 258
15.2.3 LECO CORPORATION 259
15.2.4 RIGAKU HOLDINGS CORPORATION 260
15.2.5 YOUNGIN CHROMASS 261
15.2.6 SCION INSTRUMENTS 262
15.2.7 KORE TECHNOLOGY 263
15.2.8 PROCESS INSIGHTS, INC. 264
15.2.9 MASSTECH 265
15.2.10 ADVION, INC. 266
15.2.11 SPACETEK TECHNOLOGY AG 266
15.2.12 ELEMENTAR ANALYSENSYSTEME GMBH 267
15.2.13 SKYRAY INSTRUMENTS USA, INC. 268
15.2.14 MICROSAIC SYSTEMS PLC 269
15.2.15 PFEIFFER VACUUM GMBH 270
16 RESEARCH METHODOLOGY 271
16.1 RESEARCH DATA 271
16.1.1 SECONDARY RESEARCH 272
16.1.1.1 Key secondary sources 274
16.1.1.2 Key data from secondary sources 274
16.1.2 PRIMARY RESEARCH 275
16.1.2.1 Key primary sources 275
16.1.2.2 Key supply- and demand-side participants 275
16.1.2.3 Breakdown of primary interviews 276
16.1.2.4 Key primary insights 277
16.2 MARKET SIZE ESTIMATION METHODOLOGY 277
16.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 279
16.2.2 END-USER-BASED MAPPING MARKET ESTIMATION 280
16.3 GROWTH FORECASTING MODEL 282
16.4 DATA TRIANGULATION AND MARKET BREAKDOWN 283
16.5 RESEARCH ASSUMPTIONS 284
16.6 RESEARCH LIMITATIONS 284
16.7 RISK ANALYSIS 285
17 APPENDIX 286
17.1 DISCUSSION GUIDE 286
17.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 291
17.3 CUSTOMIZATION OPTIONS 293
17.4 RELATED REPORTS 293
17.5 AUTHOR DETAILS 294

LIST OF TABLES

TABLE 1 MASS SPECTROMETRY MARKET: INCLUSIONS AND EXCLUSIONS OF STUDY 28
TABLE 2 MASS SPECTROMETRY MARKET: UNMET NEEDS 44
TABLE 3 STRATEGIC FOCUS OF TIER-1/2/3 PLAYERS 45
TABLE 4 MASS SPECTROMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 46
TABLE 5 MASS SPECTROMETRY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 51
TABLE 6 AVERAGE SELLING PRICING TREND OF MASS SPECTROMETERS, BY KEY PLAYER, 2023–2025 (USD THOUSAND) 53
TABLE 7 AVERAGE SELLING PRICING TREND OF MASS SPECTROMETERS, BY REGION, 2023–2025 (USD THOUSAND) 55
TABLE 8 IMPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 56
TABLE 9 EXPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 57
TABLE 10 MASS SPECTROMETRY MARKET: LIST OF MAJOR CONFERENCES AND
EVENTS IN 2026–2027 58
TABLE 11 CASE STUDY 1: THERMO FISHER SCIENTIFIC – ORBITRAP ASTRAL ZOOM 61
TABLE 12 CASE STUDY 2: AGILENT TECHNOLOGIES – INFINITYLAB PRO IQ SERIES 61
TABLE 13 US-ADJUSTED RECIPROCAL TARIFF RATES 62
TABLE 14 MASS SPECTROMETRY MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2024–2026 67
TABLE 15 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 70
TABLE 16 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 71
TABLE 18 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 72
TABLE 19 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 72
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 75
TABLE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS 76
TABLE 22 MASS SPECTROMETRY MARKET: LIST OF UNMET NEEDS 76
TABLE 23 MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 78
TABLE 24 MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 79
TABLE 25 MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 79
TABLE 26 HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 80
TABLE 27 HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 80
TABLE 28 TRIPLE QUADRUPOLE MASS SPECTROMETERS MARKET, BY REGION,
2024–2031 (USD MILLION) 81
TABLE 29 Q-TOF MASS SPECTROMETERS MARKET, BY REGION, 2024–2031 (USD MILLION) 82
TABLE 30 FOURIER TRANSFORM MASS SPECTROMETERS MARKET, BY REGION,
2024–2031 (USD MILLION) 83
TABLE 31 SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 84
TABLE 32 SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 84
TABLE 33 QUADRUPOLE MASS SPECTROMETERS MARKET, BY REGION,
2024–2031 (USD MILLION) 85
TABLE 34 TIME-OF-FLIGHT MASS SPECTROMETERS MARKET, BY REGION,
2024–2031 (USD MILLION) 86
TABLE 35 ION TRAP MASS SPECTROMETERS MARKET, BY REGION,
2024–2031 (USD MILLION) 87
TABLE 36 OTHER MASS SPECTROMETRY INSTRUMENTS MARKET, BY REGION,
2024–2031 (USD MILLION) 88
TABLE 37 MASS SPECTROMETRY MARKET FOR SOFTWARE & SERVICES, BY REGION,
2024–2031 (USD MILLION) 89
TABLE 38 MASS SPECTROMETRY MARKET, BY INLET TYPE, 2024–2031 USD MILLION) 91
TABLE 39 MASS SPECTROMETRY MARKET FOR LC-MS, BY REGION,
2024–2031 (USD MILLION) 93
TABLE 40 MASS SPECTROMETRY MARKET FOR GC-MS, BY REGION,
2024–2031 (USD MILLION) 94
TABLE 41 MASS SPECTROMETRY MARKET FOR ICP-MS, BY REGION,
2024–2031 USD MILLION) 95
TABLE 42 MASS SPECTROMETRY MARKET FOR OTHER INLET TYPES, BY REGION,
2024–2031 (USD MILLION) 96
TABLE 43 MASS SPECTROMETRY MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 98
TABLE 44 MASS SPECTROMETRY MARKET FOR OMICS RESEARCH, BY REGION,
2024–2031 (USD MILLION) 99
TABLE 45 MASS SPECTROMETRY MARKET FOR DRUG DISCOVERY, BY REGION,
2024–2031 (USD MILLION) 100
TABLE 46 MASS SPECTROMETRY MARKET FOR ENVIRONMENTAL TESTING, BY REGION, 2024–2031 (USD MILLION) 101
TABLE 47 MASS SPECTROMETRY MARKET FOR FOOD TESTING, BY REGION,
2024–2031 (USD MILLION) 102
TABLE 48 MASS SPECTROMETRY MARKET FOR PHARMA/BIOPHARMA MANUFACTURING,
BY REGION, 2024–2031 (USD MILLION) 103
TABLE 49 MASS SPECTROMETRY MARKET FOR CLINICAL DIAGNOSTICS, BY REGION,
2024–2031 (USD MILLION) 104
TABLE 50 MASS SPECTROMETRY MARKET FOR APPLIED SCIENCES, BY REGION,
2024–2031 (USD MILLION) 105
TABLE 51 MASS SPECTROMETRY MARKET FOR OTHER APPLICATIONS, BY REGION,
2024–2031 (USD MILLION) 106
TABLE 52 MASS SPECTROMETRY MARKET, BY END USER, 2024–2031 (USD MILLION) 108
TABLE 53 MASS SPECTROMETRY MARKET FOR PHARMACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION) 109
TABLE 54 MASS SPECTROMETRY MARKET FOR BIOTECHNOLOGY COMPANIES, BY REGION, 2024–2031 (USD MILLION) 110
TABLE 55 MASS SPECTROMETRY MARKET FOR RESEARCH LABS & ACADEMIC INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 111
TABLE 56 MASS SPECTROMETRY MARKET FOR ENVIRONMENTAL TESTING LABS, BY REGION, 2024–2031 (USD MILLION) 112
TABLE 57 MASS SPECTROMETRY MARKET FOR FOOD & BEVERAGE INDUSTRY, BY REGION, 2024–2031 (USD MILLION) 113
TABLE 58 MASS SPECTROMETRY MARKET FOR FORENSIC LABS, BY REGION,
2024–2031 (USD MILLION) 114
TABLE 59 MASS SPECTROMETRY MARKET FOR PETROCHEMICAL INDUSTRY, BY REGION, 2024–2031 (USD MILLION) 115
TABLE 60 MASS SPECTROMETRY MARKET FOR OTHER END USERS, BY REGION,
2024–2031 (USD MILLION) 116
TABLE 61 MASS SPECTROMETRY MARKET, BY REGION, 2024–2031 (USD MILLION) 118
TABLE 62 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 119
TABLE 63 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 120
TABLE 64 NORTH AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 120
TABLE 65 NORTH AMERICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 120
TABLE 66 NORTH AMERICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 121
TABLE 67 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY INLET TYPE,
2024–2031 (USD MILLION) 121
TABLE 68 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 122
TABLE 69 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY END USER,
2024–2031 (USD MILLION) 122
TABLE 70 US: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 123
TABLE 71 US: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 72 US: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 73 US: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 124
TABLE 74 CANADA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 125
TABLE 75 CANADA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 125
TABLE 76 CANADA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 126
TABLE 77 CANADA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 126
TABLE 78 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 127
TABLE 79 EUROPE: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 127
TABLE 80 EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 127
TABLE 81 EUROPE: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 82 EUROPE: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 128
TABLE 83 EUROPE: MASS SPECTROMETRY MARKET, BY INLET TYPE,
2024–2031 (USD MILLION) 128
TABLE 84 EUROPE: MASS SPECTROMETRY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 129
TABLE 85 EUROPE: MASS SPECTROMETRY MARKET, BY END USER,
2024–2031 (USD MILLION) 129
TABLE 86 GERMANY: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 130
TABLE 87 GERMANY: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 131
TABLE 88 GERMANY: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 89 GERMANY: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 131
TABLE 90 UK: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 132
TABLE 91 UK: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 133
TABLE 92 UK: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 93 UK: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 133
TABLE 94 FRANCE: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 134
TABLE 95 FRANCE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 134
TABLE 96 FRANCE: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 135
TABLE 97 FRANCE: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 135
TABLE 98 ITALY: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 136
TABLE 99 ITALY: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 136
TABLE 100 ITALY: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 136
TABLE 101 ITALY: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 137
TABLE 102 SPAIN: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 137
TABLE 103 SPAIN: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 104 SPAIN: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 105 SPAIN: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 138
TABLE 106 REST OF EUROPE: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 139
TABLE 107 REST OF EUROPE: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 139
TABLE 108 REST OF EUROPE: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 109 REST OF EUROPE: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 140
TABLE 110 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 141
TABLE 111 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 142
TABLE 112 ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 142
TABLE 113 ASIA PACIFIC: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 142
TABLE 114 ASIA PACIFIC: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 143
TABLE 115 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY INLET TYPE,
2024–2031 (USD MILLION) 143
TABLE 116 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 144
TABLE 117 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY END USER,
2024–2031 (USD MILLION) 144
TABLE 118 JAPAN: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 145
TABLE 119 JAPAN: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 146
TABLE 120 JAPAN: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE
, 2024–2031 (USD MILLION) 146
TABLE 121 JAPAN: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 146
TABLE 122 CHINA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 147
TABLE 123 CHINA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 148
TABLE 124 CHINA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 148
TABLE 125 CHINA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 148
TABLE 126 INDIA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 149
TABLE 127 INDIA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 150
TABLE 128 INDIA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 150
TABLE 129 INDIA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 150
TABLE 130 SOUTH KOREA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 151
TABLE 131 SOUTH KOREA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 152
TABLE 132 SOUTH KOREA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152
TABLE 133 SOUTH KOREA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 152
TABLE 134 AUSTRALIA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 153
TABLE 135 AUSTRALIA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 154
TABLE 136 AUSTRALIA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154
TABLE 137 AUSTRALIA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 154
TABLE 138 REST OF ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 155
TABLE 139 REST OF ASIA PACIFIC: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 155
TABLE 140 REST OF ASIA PACIFIC: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 141 REST OF ASIA PACIFIC: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 156
TABLE 142 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY,
2024–2031 (USD MILLION) 157
TABLE 143 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 157
TABLE 144 LATIN AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 157
TABLE 145 LATIN AMERICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158
TABLE 146 LATIN AMERICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 158
TABLE 147 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY INLET TYPE,
2024–2031 (USD MILLION) 158
TABLE 148 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 159
TABLE 149 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY END USER,
2024–2031 (USD MILLION) 159
TABLE 150 BRAZIL: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 160
TABLE 151 BRAZIL: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 160
TABLE 152 BRAZIL: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 161
TABLE 153 BRAZIL: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 161
TABLE 154 MEXICO: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 162
TABLE 155 MEXICO: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 162
TABLE 156 MEXICO: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 162
TABLE 157 MEXICO: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 163
TABLE 158 REST OF LATIN AMERICA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 163
TABLE 159 REST OF LATIN AMERICA: MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 164
TABLE 160 REST OF LATIN AMERICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164
TABLE 161 REST OF LATIN AMERICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 164
TABLE 162 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY REGION,
2024–2031 (USD MILLION) 165
TABLE 163 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 165
TABLE 164 MIDDLE EAST & AFRICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166
TABLE 165 MIDDLE EAST & AFRICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166
TABLE 166 MIDDLE EAST & AFRICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 166
TABLE 167 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY INLET TYPE,
2024–2031 (USD MILLION) 167
TABLE 168 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY APPLICATION,
2024–2031 (USD MILLION) 167
TABLE 169 MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY END USER,
2024–2031 (USD MILLION) 168
TABLE 170 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY OFFERING,
2024–2031 (USD MILLION) 169
TABLE 171 GCC COUNTRIES: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE,
2024–2031 (USD MILLION) 169
TABLE 172 GCC COUNTRIES: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 169
TABLE 173 GCC COUNTRIES: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET,
BY TYPE, 2024–2031 (USD MILLION) 170
TABLE 174 REST OF MIDDLE EAST & AFRICA: MASS SPECTROMETRY MARKET, BY OFFERING, 2024–2031 (USD MILLION) 170
TABLE 175 REST OF MIDDLE EAST & AFRICA: MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 176 REST OF MIDDLE EAST & AFRICA: HYBRID MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 177 REST OF MIDDLE EAST & AFRICA: SINGLE MASS SPECTROMETRY INSTRUMENTS MARKET, BY TYPE, 2024–2031 (USD MILLION) 171
TABLE 178 OVERVIEW OF STRATEGIES ADOPTED BY KEY MANUFACTURING COMPANIES, JANUARY 2022–JUNE 2026 173
TABLE 179 MASS SPECTROMETRY MARKET: DEGREE OF COMPETITION 175
TABLE 180 MASS SPECTROMETRY MARKET: OFFERING FOOTPRINT 179
TABLE 181 MASS SPECTROMETRY MARKET: APPLICATION FOOTPRINT 180
TABLE 182 MASS SPECTROMETRY MARKET: END-USER FOOTPRINT 181
TABLE 183 MASS SPECTROMETRY MARKET: REGION FOOTPRINT 182
TABLE 184 MASS SPECTROMETRY MARKET: DETAILED LIST OF KEY STARTUPS/SMES 185
TABLE 185 MASS SPECTROMETRY MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 186
TABLE 186 MASS SPECTROMETRY MARKET: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2026 190
TABLE 187 MASS SPECTROMETRY MARKET: DEALS, JANUARY 2022–JUNE 2026 192
TABLE 188 MASS SPECTROMETRY MARKET: EXPANSIONS, JANUARY 2022–JUNE 2026 193
TABLE 189 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 195
TABLE 190 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 196
TABLE 191 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 199
TABLE 192 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2022–JUNE 2026 200
TABLE 193 AGILENT TECHNOLOGIES INC.: EXPANSIONS, JANUARY 2022–JUNE 2026 201
TABLE 194 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 203
TABLE 195 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 204
TABLE 196 THERMO FISHER SCIENTIFIC, INC.: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2026 206
TABLE 197 THERMO FISHER SCIENTIFIC, INC.: DEALS, JANUARY 2022–JUNE 2026 207
TABLE 198 THERMO FISHER SCIENTIFIC, INC.: EXPANSIONS, JANUARY 2022–JUNE 2026 209
TABLE 199 WATERS CORPORATION: COMPANY OVERVIEW 211
TABLE 200 WATERS CORPORATION: PRODUCTS OFFERED 212
TABLE 201 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 214
TABLE 202 WATERS CORPORATION: DEALS, JANUARY 2022–JUNE 2026 215
TABLE 203 WATERS CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 216
TABLE 204 DANAHER CORPORATION: BUSINESS OVERVIEW 217
TABLE 205 DANAHER CORPORATION: PRODUCTS OFFERED 218
TABLE 206 DANAHER CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 220
TABLE 207 DANAHER CORPORATION: DEALS, JANUARY 2022–JUNE 2026 221
TABLE 208 DANAHER CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 221
TABLE 209 BRUKER CORPORATION: COMPANY OVERVIEW 223
TABLE 210 BRUKER CORPORATION: PRODUCTS OFFERED 224
TABLE 211 BRUKER CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 226
TABLE 212 BRUKER CORPORATION: DEALS, JANUARY 2022–JUNE 2026 227
TABLE 213 BRUKER CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 228
TABLE 214 BRUKER CORPORATION: OTHER DEVELOPMENTS 228
TABLE 215 SHIMADZU CORPORATION: COMPANY OVERVIEW 230
TABLE 216 SHIMADZU CORPORATION: PRODUCTS OFFERED 231
TABLE 217 SHIMADZU CORPORATION: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 233
TABLE 218 SHIMADZU CORPORATION: DEALS, JANUARY 2022–JUNE 2026 234
TABLE 219 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2026 235
TABLE 220 MKS INC.: COMPANY OVERVIEW 236
TABLE 221 MKS INC.: PRODUCTS OFFERED 237
TABLE 222 PERKINELMER, INC.: COMPANY OVERVIEW 238
TABLE 223 PERKINELMER, INC.: PRODUCTS OFFERED 239
TABLE 224 PERKINELMER, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2022–JUNE 2026 240
TABLE 225 PERKINELMER, INC.: DEALS, JANUARY 2022–JUNE 2026 241
TABLE 226 JEOL LTD.: COMPANY OVERVIEW 242
TABLE 227 JEOL LTD.: PRODUCTS OFFERED 243
TABLE 228 HITACHI HIGH-TECH CORPORATION: COMPANY OVERVIEW 244
TABLE 229 HITACHI HIGH-TECH CORPORATION: PRODUCTS OFFERED 245
TABLE 230 HITACHI HIGH-TECH CORPORATION: OTHER DEVELOPMENTS,
JANUARY 2022–JUNE 2026 246
TABLE 231 TELEDYNE TECHNOLOGIES INCORPORATED: COMPANY OVERVIEW 247
TABLE 232 TELEDYNE TECHNOLOGIES INCORPORATED: PRODUCTS OFFERED 248
TABLE 233 TELEDYNE TECHNOLOGIES INCORPORATED: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2026 249
TABLE 234 TELEDYNE TECHNOLOGIES INCORPORATED: DEALS, JANUARY 2022–JUNE 2026 249
TABLE 235 AMETEK, INC.: COMPANY OVERVIEW 250
TABLE 236 AMETEK, INC.: PRODUCTS OFFERED 251
TABLE 237 AMETEK, INC.: DEALS, JANUARY 2022–JUNE 2026 252
TABLE 238 JASCO: COMPANY OVERVIEW 253
TABLE 239 JASCO: PRODUCTS OFFERED 253
TABLE 240 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW 254
TABLE 241 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS OFFERED 255
TABLE 242 F. HOFFMANN-LA ROCHE LTD.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2026 256
TABLE 243 F. HOFFMANN-LA ROCHE LTD.: EXPANSIONS, JANUARY 2022–JUNE 2026 256
TABLE 244 ANALYTIK JENA GMBH: COMPANY OVERVIEW 257
TABLE 245 HIDEN ANALYTICAL: COMPANY OVERVIEW 258
TABLE 246 LECO CORPORATION: COMPANY OVERVIEW 259
TABLE 247 RIGAKU HOLDINGS CORPORATION: COMPANY OVERVIEW 260
TABLE 248 YOUNGIN CHROMASS: COMPANY OVERVIEW 261
TABLE 249 SCION INSTRUMENTS: COMPANY OVERVIEW 262
TABLE 250 KORE TECHNOLOGY: COMPANY OVERVIEW 263
TABLE 251 PROCESS INSIGHTS, INC.: COMPANY OVERVIEW 264
TABLE 252 MASSTECH: COMPANY OVERVIEW 265
TABLE 253 ADVION, INC.: COMPANY OVERVIEW 266
TABLE 254 SPACETEK TECHNOLOGY AG: COMPANY OVERVIEW 266
TABLE 255 ELEMENTAR ANALYSENSYSTEME GMBH: COMPANY OVERVIEW 267
TABLE 256 SKYRAY INSTRUMENTS USA, INC.: COMPANY OVERVIEW 268
TABLE 257 MICROSAIC SYSTEMS PLC: COMPANY OVERVIEW 269
TABLE 258 PFEIFFER VACUUM GMBH: COMPANY OVERVIEW 270
TABLE 259 MASS SPECTROMETRY MARKET: RISK ANALYSIS 285

LIST OF FIGURES

FIGURE 1 MASS SPECTROMETRY MARKET SEGMENTATION AND REGIONAL SCOPE 27
FIGURE 2 MASS SPECTROMETRY MARKET: YEARS CONSIDERED 29
FIGURE 3 MARKET SCENARIO 31
FIGURE 4 MASS SPECTROMETRY MARKET, 2024–2031 31
FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN MASS SPECTROMETRY MARKET, 2023–2026 32
FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF MASS SPECTROMETRY MARKET 33
FIGURE 7 HIGH-GROWTH SEGMENTS IN MASS SPECTROMETRY MARKET, 2026–2031 34
FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 35
FIGURE 9 INCREASED DEMAND FOR ON-SITE TESTING TO DRIVE MARKET 36
FIGURE 10 LC-MS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 37
FIGURE 11 CHINA TO REGISTER HIGHEST CAGR FROM 2026 TO 2031 38
FIGURE 12 MASS SPECTROMETRY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 39
FIGURE 13 MASS SPECTROMETRY MARKET: PORTER’S FIVE FORCES ANALYSIS 46
FIGURE 14 MASS SPECTROMETRY MARKET: VALUE CHAIN ANALYSIS 49
FIGURE 15 MASS SPECTROMETRY MARKET: ECOSYSTEM ANALYSIS 50
FIGURE 16 AVERAGE SELLING PRICE TREND OF MASS SPECTROMETERS, BY KEY PLAYER, 2023–2025 52
FIGURE 17 AVERAGE SELLING PRICE TREND OF MASS SPECTROMETERS, BY REGION,
2023–2025 54
FIGURE 18 IMPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 56
FIGURE 19 EXPORT DATA FOR HS CODE 902781-COMPLIANT PRODUCTS, BY COUNTRY, 2022–2025 (USD THOUSAND) 57
FIGURE 20 NEW REVENUE POCKETS FOR PLAYERS IN MASS SPECTROMETRY MARKET 59
FIGURE 21 MASS SPECTROMETRY MARKET: INVESTMENT AND FUNDING SCENARIO,
2019–2023 (USD MILLION) 59
FIGURE 22 NUMBER OF DEALS IN MASS SPECTROMETRY MARKET, BY KEY PLAYER,
2019–2023 60
FIGURE 23 VALUE OF DEALS IN MASS SPECTROMETRY MARKET, BY KEY PLAYER,
2019–2023 (USD MILLION) 60
FIGURE 24 MASS SPECTROMETRY MARKET: PATENT ANALYSIS,
JANUARY 2015–DECEMBER 2025 66
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS 75
FIGURE 26 KEY BUYING CRITERIA, BY END USER 75
FIGURE 27 NORTH AMERICA: MASS SPECTROMETRY MARKET SNAPSHOT 119
FIGURE 28 ASIA PACIFIC: MASS SPECTROMETRY MARKET SNAPSHOT 141
FIGURE 29 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MASS SPECTROMETRY MARKET, 2021–2025 174
FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS IN MASS SPECTROMETRY MARKET, 2025 175
FIGURE 31 MASS SPECTROMETRY MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 177
FIGURE 32 MASS SPECTROMETRY MARKET: COMPANY FOOTPRINT 178
FIGURE 33 MASS SPECTROMETRY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 184
FIGURE 34 EV/EBITDA OF KEY VENDORS 187
FIGURE 35 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 188
FIGURE 36 MASS SPECTROMETRY MARKET: BRAND COMPARATIVE ANALYSIS 189
FIGURE 37 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 196
FIGURE 38 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 204
FIGURE 39 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 212
FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 218
FIGURE 41 BRUKER CORPORATION: COMPANY SNAPSHOT (2025) 224
FIGURE 42 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2025) 231
FIGURE 43 MKS INC.: COMPANY SNAPSHOT (2025) 237
FIGURE 44 PERKINELMER: COMPANY SNAPSHOT (2023) 239
FIGURE 45 JEOL: COMPANY SNAPSHOT (2025) 242
FIGURE 46 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT (2025) 245
FIGURE 47 TELEDYNE TECHNOLOGIES INCORPORATED: COMPANY SNAPSHOT (2025) 248
FIGURE 48 AMETEK, INC.: COMPANY SNAPSHOT (2025) 251
FIGURE 49 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2025) 255
FIGURE 50 MASS SPECTROMETRY MARKET: RESEARCH DATA 271
FIGURE 51 MASS SPECTROMETRY MARKET: RESEARCH DESIGN 272
FIGURE 52 MASS SPECTROMETRY MARKET: KEY SECONDARY SOURCES 274
FIGURE 53 MASS SPECTROMETRY MARKET: KEY DATA FROM SECONDARY SOURCES 274
FIGURE 54 MASS SPECTROMETRY MARKET: KEY PRIMARY SOURCES
(DEMAND AND SUPPLY SIDES) 275
FIGURE 55 MASS SPECTROMETRY MARKET: KEY SUPPLY- AND DEMAND-SIDE PARTICIPANTS 275
FIGURE 56 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 276
FIGURE 57 MASS SPECTROMETRY MARKET: KEY INSIGHTS FROM PRIMARY EXPERTS 277
FIGURE 58 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 278
FIGURE 59 MASS SPECTROMETRY MARKET: COMPANY REVENUE ESTIMATION, 2025 280
FIGURE 60 MASS SPECTROMETRY MARKET: MARKET SIZE ESTIMATION METHODOLOGY 281
FIGURE 61 MASS SPECTROMETRY MARKET: GROWTH PROJECTIONS BASED ON REVENUE IMPACT OF KEY MACRO INDICATORS 282
FIGURE 62 DATA TRIANGULATION 283

---

---